These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7897323

  • 21. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice.
    Yagyu H, Ishibashi S, Chen Z, Osuga J, Okazaki M, Perrey S, Kitamine T, Shimada M, Ohashi K, Harada K, Shionoiri F, Yahagi N, Gotoda T, Yazaki Y, Yamada N.
    J Lipid Res; 1999 Sep; 40(9):1677-85. PubMed ID: 10484615
    [Abstract] [Full Text] [Related]

  • 22. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
    Pastore L, Belalcazar LM, Oka K, Cela R, Lee B, Chan L, Beaudet AL.
    Gene; 2004 Mar 03; 327(2):153-60. PubMed ID: 14980712
    [Abstract] [Full Text] [Related]

  • 23. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
    Spangenberg J, Curtiss LK.
    Biochim Biophys Acta; 1997 Nov 15; 1349(2):109-21. PubMed ID: 9421184
    [Abstract] [Full Text] [Related]

  • 24. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
    Li H, Reddick RL, Maeda N.
    Arterioscler Thromb; 1993 Dec 15; 13(12):1814-21. PubMed ID: 8241102
    [Abstract] [Full Text] [Related]

  • 25. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.
    Sorci-Thomas MG, Zabalawi M, Bharadwaj MS, Wilhelm AJ, Owen JS, Asztalos BF, Bhat S, Thomas MJ.
    Biochim Biophys Acta; 2012 Mar 15; 1821(3):502-12. PubMed ID: 21944998
    [Abstract] [Full Text] [Related]

  • 26. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142).
    Fazio S, Sanan DA, Lee YL, Ji ZS, Mahley RW, Rall SC.
    Arterioscler Thromb; 1994 Nov 15; 14(11):1873-9. PubMed ID: 7947615
    [Abstract] [Full Text] [Related]

  • 27. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
    Moore RE, Kawashiri MA, Kitajima K, Secreto A, Millar JS, Pratico D, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1914-20. PubMed ID: 12933536
    [Abstract] [Full Text] [Related]

  • 28. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.
    Christoffersen C, Jauhiainen M, Moser M, Porse B, Ehnholm C, Boesl M, Dahlbäck B, Nielsen LB.
    J Biol Chem; 2008 Jan 25; 283(4):1839-47. PubMed ID: 18006500
    [Abstract] [Full Text] [Related]

  • 29. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo.
    Ishiguro H, Yoshida H, Major AS, Zhu T, Babaev VR, Linton MF, Fazio S.
    J Biol Chem; 2001 Sep 28; 276(39):36742-8. PubMed ID: 11477092
    [Abstract] [Full Text] [Related]

  • 30. Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice.
    Kawashiri MA, Zhang Y, Puré E, Rader DJ.
    Atherosclerosis; 2002 Nov 28; 165(1):15-22. PubMed ID: 12208466
    [Abstract] [Full Text] [Related]

  • 31. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
    Tiniakou I, Kanaki Z, Georgopoulos S, Chroni A, Van Eck M, Fotakis P, Zannis VI, Kardassis D.
    Atherosclerosis; 2015 Nov 28; 243(1):77-85. PubMed ID: 26363436
    [Abstract] [Full Text] [Related]

  • 32. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW, Amar MJ, Lambert G, Vaisman BL, Paigen B, Najib-Fruchart J, Hoyt RF, Neufeld ED, Remaley AT, Fredrickson DS, Brewer HB, Santamarina-Fojo S.
    Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):407-12. PubMed ID: 11752403
    [Abstract] [Full Text] [Related]

  • 33. High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?
    Stein O, Dabach Y, Hollander G, Ben-Naim M, Halperin G, Stein Y.
    Atherosclerosis; 1999 Jun 08; 144(2):367-74. PubMed ID: 10407497
    [Abstract] [Full Text] [Related]

  • 34. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
    Tsukamoto K, Hiester KG, Smith P, Usher DC, Glick JM, Rader DJ.
    J Lipid Res; 1997 Sep 08; 38(9):1869-76. PubMed ID: 9323596
    [Abstract] [Full Text] [Related]

  • 35. HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis.
    Hughes SD, Verstuyft J, Rubin EM.
    Arterioscler Thromb Vasc Biol; 1997 Sep 08; 17(9):1725-9. PubMed ID: 9327769
    [Abstract] [Full Text] [Related]

  • 36. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.
    Lou XJ, Boonmark NW, Horrigan FT, Degen JL, Lawn RM.
    Proc Natl Acad Sci U S A; 1998 Oct 13; 95(21):12591-5. PubMed ID: 9770530
    [Abstract] [Full Text] [Related]

  • 37. The apolipoprotein(a) gene: characterization of 5' flanking regions and expression in transgenic mice.
    Lawn RM.
    Chem Phys Lipids; 1994 Jan 13; 67-68():19-23. PubMed ID: 8187213
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.
    Duverger N, Kruth H, Emmanuel F, Caillaud JM, Viglietta C, Castro G, Tailleux A, Fievet C, Fruchart JC, Houdebine LM, Denefle P.
    Circulation; 1996 Aug 15; 94(4):713-7. PubMed ID: 8772693
    [Abstract] [Full Text] [Related]

  • 39. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet.
    Baroukh N, Ostos MA, Vergnes L, Recalde D, Staels B, Fruchart J, Ochoa A, Castro G, Zakin MM.
    FEBS Lett; 2001 Jul 27; 502(1-2):16-20. PubMed ID: 11478940
    [Abstract] [Full Text] [Related]

  • 40. Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice.
    Declercq V, Yeganeh B, Moshtaghi-Kashanian GR, Khademi H, Bahadori B, Moghadasian MH.
    J Cardiovasc Pharmacol; 2005 Jul 27; 46(1):18-24. PubMed ID: 15965350
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.